Control Formula
OtherFeeding ad libitum
Other names: Commercially available Infant Formula
NCT Number: NCT01808105
To evaluate growth and tolerance of healthy term infants fed experimental infant formulas, a commercial infant formula and human breast milk.
Looking for future studies?
Notify MeUp to 5 day
All sexes
Interventional
Not applicable
Clinical Research Puerto Rico, Guayama, Puerto Rico
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Feeding ad libitum
Other names: Commercially available Infant Formula
Feeding ad libitum
Feeding ad libitum
Feeding ad libitum
Other names: Breast feeding group
Time frame: Study Day (SD) 14 - 119
Weight gain per day
Time frame: Study Day (SD) 1-28; 3 Day Records prior to SD 42, 84 and 119 visits
Stool consistency and number per day
Time frame: Study Day (SD) 1-28; 3 Day Records prior to SD 42, 84 and 119 visits
% of feedings with spit up associated with feeding
Time frame: Study Day (SD) 1, 14, 28, 42, 84 and 119 visits
Length and interval length gain per day
Time frame: Study Day (SD) 1, 14, 28, 42, 84 and 119 visits
Head circumference (HC) and interval HC gain per day
Time frame: Study Day (SD) 1-28; 3 Day Records prior to SD 42, 84 and 119 visits
Average volume of study formula intake and average number of study formula feedings per day
Time frame: Study Day (SD) 42 and 119 visits
Infant urine sample
Abbott Nutrition
Industry
Growth and Tolerance of Young Infants Fed Infant Formulas
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04105686
Growth and Tolerance
Birmingham, Alabama, United States
View Trial DetailsNCT02006992
Growth and Tolerance
Little Rock, Arkansas, United States
View Trial Details